| First Author | Knebel B | Year | 2015 |
| Journal | Biochim Biophys Acta | Volume | 1851 |
| Issue | 7 | Pages | 965-76 |
| PubMed ID | 25790917 | Mgi Jnum | J:230549 |
| Mgi Id | MGI:5762772 | Doi | 10.1016/j.bbalip.2015.03.003 |
| Citation | Knebel B, et al. (2015) Peroxisomes compensate hepatic lipid overflow in mice with fatty liver. Biochim Biophys Acta 1851(7):965-76 |
| abstractText | Major causes of lipid accumulation in liver are increased import or synthesis or decreased catabolism of fatty acids. The latter is caused by dysfunction of cellular organelles controlling energy homeostasis, i.e., mitochondria. Peroxisomes also appear to be an important organelle in lipid metabolism of hepatocytes, but little is known about their role in the development of non-alcoholic fatty liver disease (NAFLD). To investigate the role of peroxisomes alongside mitochondria in excessive hepatic lipid accumulation, we used leptin-resistant db/db mice on C57BLKS background, a mouse model that develops hyperphagia-induced diabetes with obesity and NAFLD. Proteome and gene expression analyses along with lipid analyses in the liver revealed differential expression of genes related to lipid metabolism and beta-oxidation, whereas genes for peroxisomal proteins were predominantly regulated. CONCLUSION: Our investigations show that in fatty liver disease in combination with obesity and diabetes, the hepatocyte-protecting organelle peroxisome is altered. Hence, peroxisomes might indicate a stage of pre-NAFLD, play a role in the early development of NAFLD and appear to be a potential target for treatment and prevention of NAFLD. |
